Skip to main content

EW Healthcare Partners, L.P.'s Form 4 filing

EyePoint, Inc.EYPT · filed Sep 1, 2023

Accession no.
0000899243-23-018636
Filed
Sep 1, 2023, 4:51 PM ET
Trade date
Aug 30-31, 2023
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 4 non-derivative transactions. Open-market sales total $1.47M. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
EW Healthcare Partners, L.P.CIK 000161234310% Owner, Other: See footnotes 1 and 6
Essex Woodlands Fund IX-GP, L.P.CIK 000165228510% Owner
Essex Woodlands IX, LLCCIK 000165228610% Owner
EW Healthcare Partners-A, L.P.CIK 000173624010% Owner, Other: See footnotes 1 and 6

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 30, 2023Common Stock, $0.001 par valueSSaleDisposed−60,649$10.92F2−$662,432.643,589,743Indirect
Aug 30, 2023Common Stock, $0.001 par valueSSaleDisposed−327$11.36F3−$3,714.563,589,416Indirect
Aug 31, 2023Common Stock, $0.001 par valueSSaleDisposed−71,478$10.17F4−$726,723.973,517,938Indirect
Aug 31, 2023Common Stock, $0.001 par valueSSaleDisposed−7,017$11.02F5−$77,337.163,510,921Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $10.32 to $11.29. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F3

Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $11.35 to $11.37. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F4

Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $9.83 to $10.76. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

F5

Price is the volume weighted average selling price of all sales by the Reporting Persons on the transaction date within a one dollar range. Actual prices ranged from $10.84 to $11.23. The Reporting Persons hereby undertake to provide upon request of the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)